Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2014

Open Access 01-12-2014 | Research article

Normal values of exhaled carbon monoxide in healthy subjects: comparison between two methods of assessment

Authors: Umberto Moscato, Andrea Poscia, Riccardo Gargaruti, Giovanni Capelli, Franco Cavaliere

Published in: BMC Pulmonary Medicine | Issue 1/2014

Login to get access

Abstract

Background

In a previous study, exhaled carbon monoxide (eCO) has been assessed in healthy non-smokers with a photo acoustic spectrometer Brüel&Kjær 1312. Unexpectedly, values were higher than those reported in literature, which were mostly obtained with electrochemical analysers. This study was aimed to compare eCO values obtained with Brüel&Kjær 1312 and PiCO + Smokerlyzer, a largely utilized electrochemical analyser.

Methods

Thirty-four healthy subjects, 15 non-smokers and 19 smokers, underwent eCO assessment with Brüel&Kjær 1312 and PiCO + Smokerlyzer during a prolonged expiration (15 seconds). Brüel&Kjær 1312 assessed CO concentration 7 and 12 seconds after the beginning of expiration and displayed the mean value. PiCO + Smokerlyzer was utilized according to the manufacturer’s recommendations. In vitro, the two devices were tested with standard concentrations of CO in nitrogen (5, 9.9, 20, and 50 ppm), and the time needed by PiCO + Smokerlyzer readings to stabilize was assessed at different gas flows.

Results

Both Brüel&Kjær 1312 and PiCO + Smokerlyzer presented very good internal consistency. The values provided were strictly correlated, but at low test concentrations, the Brüel&Kjær 1312 readings were greater than the PiCO + Smokerlyzer, and vice versa. PiCO + Smokerlyzer overestimated the CO standard concentrations at 5 and 9.9 ppm by 20%, while Brüel&Kjær 1312 measures were correct. PiCO + Smokerlyzer readings stabilized in 12 seconds during in vitro tests and in 15 seconds during in vivo measurements, suggesting that the values displayed corresponded to the initial phase of expiration.

Conclusions

Differences between Brüel&Kjær 1312 and PiCO + Smokerlyzer may be explained because Brüel&Kjær 1312 measured CO levels in the middle and at the end of expiration while PiCO + Smokerlyzer assessed them in the initial part of expiration.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zhou M, Liu Y, Duan Y: Breath biomarkers in diagnosis of pulmonary diseases. Clin Chim Acta. 2012, 413 (21–22): 1770-1780.CrossRefPubMed Zhou M, Liu Y, Duan Y: Breath biomarkers in diagnosis of pulmonary diseases. Clin Chim Acta. 2012, 413 (21–22): 1770-1780.CrossRefPubMed
2.
go back to reference Ryter SW, Alam J, Choi AM: Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006, 86 (2): 583-650. 10.1152/physrev.00011.2005.CrossRefPubMed Ryter SW, Alam J, Choi AM: Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006, 86 (2): 583-650. 10.1152/physrev.00011.2005.CrossRefPubMed
3.
go back to reference Owens EO: Endogenous carbon monoxide production in disease. Clin Biochem. 2010, 43 (15): 1183-1188. 10.1016/j.clinbiochem.2010.07.011.CrossRefPubMed Owens EO: Endogenous carbon monoxide production in disease. Clin Biochem. 2010, 43 (15): 1183-1188. 10.1016/j.clinbiochem.2010.07.011.CrossRefPubMed
4.
go back to reference Sylvester KP, Patey RA, Rafferty GF, Rees D, Thein SL, Greenough A: Exhaled carbon monoxide levels in children with sickle cell disease. Eur J Pediatr. 2005, 164 (3): 162-165. 10.1007/s00431-004-1605-8.CrossRefPubMed Sylvester KP, Patey RA, Rafferty GF, Rees D, Thein SL, Greenough A: Exhaled carbon monoxide levels in children with sickle cell disease. Eur J Pediatr. 2005, 164 (3): 162-165. 10.1007/s00431-004-1605-8.CrossRefPubMed
5.
6.
go back to reference Zegdi R, Perrin D, Burdin M, Boiteau R, Tenaillon A: Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med. 2002, 28 (6): 793-796. 10.1007/s00134-002-1269-7.CrossRefPubMed Zegdi R, Perrin D, Burdin M, Boiteau R, Tenaillon A: Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med. 2002, 28 (6): 793-796. 10.1007/s00134-002-1269-7.CrossRefPubMed
7.
go back to reference Morimatsu H, Takahashi T, Matsusaki T, Hayashi M, Matsumi J, Shimizu H, Matsumi M, Morita K: An increase in exhaled CO concentration in systemic inflammation/sepsis. J Breath Res. 2010, 4 (4): 047103-10.1088/1752-7155/4/4/047103.CrossRefPubMed Morimatsu H, Takahashi T, Matsusaki T, Hayashi M, Matsumi J, Shimizu H, Matsumi M, Morita K: An increase in exhaled CO concentration in systemic inflammation/sepsis. J Breath Res. 2010, 4 (4): 047103-10.1088/1752-7155/4/4/047103.CrossRefPubMed
8.
go back to reference Antuni JD, Kharitonov SA, Hughes D, Hodson ME, Barnes PJ: Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax. 2000, 55 (2): 138-142. 10.1136/thorax.55.2.138.CrossRefPubMedPubMedCentral Antuni JD, Kharitonov SA, Hughes D, Hodson ME, Barnes PJ: Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis. Thorax. 2000, 55 (2): 138-142. 10.1136/thorax.55.2.138.CrossRefPubMedPubMedCentral
9.
go back to reference De las Heras D, Fernandez J, Gines P, Cardenas A, Ortega R, Navasa M, Barbera JA, Calahorra B, Guevara M, Bataller R, Jimenez W, Arroyo V, Rodes J: Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology. 2003, 38 (2): 452-459. 10.1053/jhep.2003.50304.CrossRefPubMed De las Heras D, Fernandez J, Gines P, Cardenas A, Ortega R, Navasa M, Barbera JA, Calahorra B, Guevara M, Bataller R, Jimenez W, Arroyo V, Rodes J: Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology. 2003, 38 (2): 452-459. 10.1053/jhep.2003.50304.CrossRefPubMed
10.
go back to reference Matsusaki T, Morimatsu H, Takahashi T, Matsumi M, Sato K, Kaku R, Sato T, Yagi T, Tanaka N, Morita K: Increased exhaled carbon monoxide concentration during living donor liver transplantation. Int J Mol Med. 2008, 21 (1): 75-81.PubMed Matsusaki T, Morimatsu H, Takahashi T, Matsumi M, Sato K, Kaku R, Sato T, Yagi T, Tanaka N, Morita K: Increased exhaled carbon monoxide concentration during living donor liver transplantation. Int J Mol Med. 2008, 21 (1): 75-81.PubMed
11.
go back to reference Ohara Y, Ohara T, Ohrui T, Morikawa T, Asamura T, Sasaki H, Arai H: Exhaled carbon monoxide levels in preschool-age children with episodic asthma. Pediatr Int. 2012, 54 (2): 227-232. 10.1111/j.1442-200X.2011.03515.x.CrossRefPubMed Ohara Y, Ohara T, Ohrui T, Morikawa T, Asamura T, Sasaki H, Arai H: Exhaled carbon monoxide levels in preschool-age children with episodic asthma. Pediatr Int. 2012, 54 (2): 227-232. 10.1111/j.1442-200X.2011.03515.x.CrossRefPubMed
12.
go back to reference Pearson P, Lewis S, Britton J, Fogarty A: Exhaled carbon monoxide levels in atopic asthma: a longitudinal study. Respir Med. 2005, 99 (10): 1292-1296. 10.1016/j.rmed.2005.02.042.CrossRefPubMed Pearson P, Lewis S, Britton J, Fogarty A: Exhaled carbon monoxide levels in atopic asthma: a longitudinal study. Respir Med. 2005, 99 (10): 1292-1296. 10.1016/j.rmed.2005.02.042.CrossRefPubMed
13.
go back to reference Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H: Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1997, 156 (4 Pt 1): 1140-1143.CrossRefPubMed Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H: Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1997, 156 (4 Pt 1): 1140-1143.CrossRefPubMed
14.
go back to reference Yasuda H, Sasaki T, Yamaya M, Ebihara S, Maruyama M, Kanda A, Sasaki H: Increased arteriovenous carboxyhemoglobin differences in patients with inflammatory pulmonary diseases. Chest. 2004, 125 (6): 2160-2168. 10.1378/chest.125.6.2160.CrossRefPubMed Yasuda H, Sasaki T, Yamaya M, Ebihara S, Maruyama M, Kanda A, Sasaki H: Increased arteriovenous carboxyhemoglobin differences in patients with inflammatory pulmonary diseases. Chest. 2004, 125 (6): 2160-2168. 10.1378/chest.125.6.2160.CrossRefPubMed
15.
go back to reference Yamaya M, Sekizawa K, Ishizuka S, Monma M, Mizuta K, Sasaki H: Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections. Am J Respir Crit Care Med. 1998, 158: 311-314. 10.1164/ajrccm.158.1.9711066.CrossRefPubMed Yamaya M, Sekizawa K, Ishizuka S, Monma M, Mizuta K, Sasaki H: Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections. Am J Respir Crit Care Med. 1998, 158: 311-314. 10.1164/ajrccm.158.1.9711066.CrossRefPubMed
16.
go back to reference Biernacki WA, Kharitonov SA, Barnes PJ: Exhaled carbon monoxide in patients with lower respiratory tract infection. Respir Med. 2001, 95 (12): 1003-1005. 10.1053/rmed.2001.1196.CrossRefPubMed Biernacki WA, Kharitonov SA, Barnes PJ: Exhaled carbon monoxide in patients with lower respiratory tract infection. Respir Med. 2001, 95 (12): 1003-1005. 10.1053/rmed.2001.1196.CrossRefPubMed
17.
go back to reference Horvath I, Loukides S, Wodehouse T, Kharitonov SA, Cole PJ, Barnes PJ: Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax. 1998, 53 (10): 867-870. 10.1136/thx.53.10.867.CrossRefPubMedPubMedCentral Horvath I, Loukides S, Wodehouse T, Kharitonov SA, Cole PJ, Barnes PJ: Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax. 1998, 53 (10): 867-870. 10.1136/thx.53.10.867.CrossRefPubMedPubMedCentral
18.
go back to reference Monma M, Yamaya M, Sekizawa K, Ikeda K, Suzuki N, Kikuchi T, Takasasa T, Sasaki H: Increased carbon monoxide in exhaled air of patients with seasonal allergic rhinitis. Clin Exp Allergy. 1999, 29: 1537-1541. 10.1046/j.1365-2222.1999.00684.x.CrossRefPubMed Monma M, Yamaya M, Sekizawa K, Ikeda K, Suzuki N, Kikuchi T, Takasasa T, Sasaki H: Increased carbon monoxide in exhaled air of patients with seasonal allergic rhinitis. Clin Exp Allergy. 1999, 29: 1537-1541. 10.1046/j.1365-2222.1999.00684.x.CrossRefPubMed
19.
go back to reference Vos R, Cordemans C, Vanaudenaerde BM, De Vleeschauwer SI, Schoonis A, Van Raemdonck DE, Dupont LJ, Verleden GM: Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation. Transplantation. 2009, 87 (10): 1579-1583. 10.1097/TP.0b013e3181a4e69c.CrossRefPubMed Vos R, Cordemans C, Vanaudenaerde BM, De Vleeschauwer SI, Schoonis A, Van Raemdonck DE, Dupont LJ, Verleden GM: Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation. Transplantation. 2009, 87 (10): 1579-1583. 10.1097/TP.0b013e3181a4e69c.CrossRefPubMed
20.
go back to reference Kharitonov SA, Barnes PJ: Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers. 2002, 7 (1): 1-32. 10.1080/13547500110104233.CrossRefPubMed Kharitonov SA, Barnes PJ: Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers. 2002, 7 (1): 1-32. 10.1080/13547500110104233.CrossRefPubMed
21.
go back to reference Paredi P, Kharitonov SA, Barnes PJ: Analysis of expired air for oxidation products. Am J Respir Crit Care Med. 2002, 166 (12 Pt 2): S31-S37.CrossRefPubMed Paredi P, Kharitonov SA, Barnes PJ: Analysis of expired air for oxidation products. Am J Respir Crit Care Med. 2002, 166 (12 Pt 2): S31-S37.CrossRefPubMed
22.
go back to reference Cavaliere F, Volpe C, Gargaruti R, Poscia A, Di Donato M, Grieco G, Moscato U: Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers. BMC Pulmonary Medicine. 2009, 9: 51-10.1186/1471-2466-9-51.CrossRefPubMedPubMedCentral Cavaliere F, Volpe C, Gargaruti R, Poscia A, Di Donato M, Grieco G, Moscato U: Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers. BMC Pulmonary Medicine. 2009, 9: 51-10.1186/1471-2466-9-51.CrossRefPubMedPubMedCentral
23.
go back to reference Harren FJM, Cotti G, Oomens J, Lintel Hekkert S: Encyclopedia of Analytical Chemistry. Photoacoustic spectroscopy in trace gas monitoring. Edited by: Meyers RA. 2000, Chichester: John Wiley & Sons Ltd, 2203-2226. Harren FJM, Cotti G, Oomens J, Lintel Hekkert S: Encyclopedia of Analytical Chemistry. Photoacoustic spectroscopy in trace gas monitoring. Edited by: Meyers RA. 2000, Chichester: John Wiley & Sons Ltd, 2203-2226.
24.
go back to reference Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.CrossRefPubMed Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.CrossRefPubMed
25.
go back to reference Shorter H, Nelson D, McManus JB, Zahniser MS, Sama S, Milton DK: Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy. J Breath Res. 2011, 5 (3): 037108-10.1088/1752-7155/5/3/037108.CrossRefPubMedPubMedCentral Shorter H, Nelson D, McManus JB, Zahniser MS, Sama S, Milton DK: Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy. J Breath Res. 2011, 5 (3): 037108-10.1088/1752-7155/5/3/037108.CrossRefPubMedPubMedCentral
26.
go back to reference Sowa M, Mürtz , Hering P: Mid-infrared laser spectroscopy for online analysis of exhaled CO. J. Breath Res. 2010, 4 (4): 047101-10.1088/1752-7155/4/4/047101.CrossRefPubMed Sowa M, Mürtz , Hering P: Mid-infrared laser spectroscopy for online analysis of exhaled CO. J. Breath Res. 2010, 4 (4): 047101-10.1088/1752-7155/4/4/047101.CrossRefPubMed
27.
go back to reference Chivers LL, Higgins ST, Heil SH, Proskin RW, Thomas CS: Effects of initial abstinence and pro¬grammed lapses on the relative reinforcing effects of cigarette smoking. J Appl Behav Anal. 2008, 41 (4): 481-497. 10.1901/jaba.2008.41-481.CrossRefPubMedPubMedCentral Chivers LL, Higgins ST, Heil SH, Proskin RW, Thomas CS: Effects of initial abstinence and pro¬grammed lapses on the relative reinforcing effects of cigarette smoking. J Appl Behav Anal. 2008, 41 (4): 481-497. 10.1901/jaba.2008.41-481.CrossRefPubMedPubMedCentral
28.
go back to reference Dallery J, Glenn IM, Raiff BR: An Internet-based abstinence reinforcement treatment for cigarette smoking. Drug Alcohol Depend. 2007, 86 (2–3): 230-238.CrossRefPubMed Dallery J, Glenn IM, Raiff BR: An Internet-based abstinence reinforcement treatment for cigarette smoking. Drug Alcohol Depend. 2007, 86 (2–3): 230-238.CrossRefPubMed
29.
go back to reference Rose JE, Salley A, Behm FM, Bates JE, Westman EC: Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. Psychopharmacology (Berl). 2010, 210 (1): 1-12. 10.1007/s00213-010-1810-2.CrossRef Rose JE, Salley A, Behm FM, Bates JE, Westman EC: Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. Psychopharmacology (Berl). 2010, 210 (1): 1-12. 10.1007/s00213-010-1810-2.CrossRef
30.
go back to reference Terheggen-Lagro SW, Bink MW, Vreman HJ, van der Ent CK: End-tidal carbon monoxide corrected for lung volume is elevated in patients with cystic fibrosis. Am J Respir Crit Care Med. 2003, 168 (10): 1227-1231. 10.1164/rccm.200302-248OC.CrossRefPubMed Terheggen-Lagro SW, Bink MW, Vreman HJ, van der Ent CK: End-tidal carbon monoxide corrected for lung volume is elevated in patients with cystic fibrosis. Am J Respir Crit Care Med. 2003, 168 (10): 1227-1231. 10.1164/rccm.200302-248OC.CrossRefPubMed
31.
go back to reference Raiff BR, Faix C, Turturici M, Dallery J: Breath carbon monoxide output is affected by speed of emptying the lungs: implications for laboratory and smoking cessation research. Nicotine Tob Res. 2010, 12 (8): 834-838. 10.1093/ntr/ntq090.CrossRefPubMedPubMedCentral Raiff BR, Faix C, Turturici M, Dallery J: Breath carbon monoxide output is affected by speed of emptying the lungs: implications for laboratory and smoking cessation research. Nicotine Tob Res. 2010, 12 (8): 834-838. 10.1093/ntr/ntq090.CrossRefPubMedPubMedCentral
32.
go back to reference Schober P, Kalmanowicz M, Loer SA: Effects of inspiratory oxygen concentration on endtidal carbon monoxide concentration. J Clin Monit Comput. 2006, 20 (2): 89-94. 10.1007/s10877-006-9011-6.CrossRefPubMed Schober P, Kalmanowicz M, Loer SA: Effects of inspiratory oxygen concentration on endtidal carbon monoxide concentration. J Clin Monit Comput. 2006, 20 (2): 89-94. 10.1007/s10877-006-9011-6.CrossRefPubMed
33.
go back to reference Grippi MA: Respiratory mechanics. Pulmonary Pathophysiology. 1995, Philadelphia, PA: Lippincott, Williams & Wilkins, 13-39. Grippi MA: Respiratory mechanics. Pulmonary Pathophysiology. 1995, Philadelphia, PA: Lippincott, Williams & Wilkins, 13-39.
Metadata
Title
Normal values of exhaled carbon monoxide in healthy subjects: comparison between two methods of assessment
Authors
Umberto Moscato
Andrea Poscia
Riccardo Gargaruti
Giovanni Capelli
Franco Cavaliere
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2014
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-14-204

Other articles of this Issue 1/2014

BMC Pulmonary Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.